Your browser doesn't support javascript.
loading
Clinical and regulatory landscape for cardiogenic shock: A report from the Cardiac Safety Research Consortium ThinkTank on cardiogenic shock.
Samsky, Marc; Krucoff, Mitchell; Althouse, Andrew D; Abraham, William T; Adamson, Philip; Aguel, Fernando; Bilazarian, Seth; Dangas, George D; Gilchrist, Ian C; Henry, Timothy D; Hochman, Judith S; Kapur, Navin K; Laschinger, John; Masters, Roy G; Michelson, Eric; Morrow, David A; Morrow, Valarie; Ohman, E Magnus; Pina, Ileana; Proudfoot, Alastair G; Rogers, Joseph; Sapirstein, John; Senatore, Fred; Stockbridge, Norman; Thiele, Holger; Truesdell, Alexander G; Waksman, Ron; Rao, Sunil.
Afiliação
  • Samsky M; Duke University Medical Center, Duke Clinical Research Institute, Durham Veterans Administration, Durham, NC. Electronic address: marc.samsky@duke.edu.
  • Krucoff M; Duke University Medical Center, Cardiovascular Devices Unit, eECG Core Laboratories, Duke Clinical Research Institute, Durham, NC. Electronic address: mitchell.krucoff@duke.edu.
  • Althouse AD; Center for Research on Healthcare Data Center (CRHC-DC), Center for Clinical Trials & Data Coordination (CCDC), Division of General Internal Medicine, University of Pittsburgh School of Medicine, Circulation: Cardiovascular Interventions, Pittsburgh, PA. Electronic address: althousead@upmc.edu.
  • Abraham WT; Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH. Electronic address: william.abraham@osumc.edu.
  • Adamson P; Abbott, Austin, TX. Electronic address: Philip.adamson@abbott.com.
  • Aguel F; Office of Product Evaluation and Quality, CDRH | Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD. Electronic address: Fernando.Aguel@fda.hhs.gov.
  • Bilazarian S; Abiomed, Danvers, MA. Electronic address: sbilazarian@abiomed.com.
  • Dangas GD; Mount Sinai Medical Center, New York, NY. Electronic address: George.Dangas@mountsinai.org.
  • Gilchrist IC; Pennsylvania State University, Heart and Vascular Institute, Hershey, PA. Electronic address: icg1@psu.edu.
  • Henry TD; The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, The Carl and Edyth Lindner Family Distinguished Chair in Clinical Research, The Christ Hospital Health Network, Cincinnati, OH. Electronic address: Tim.Henry@thechristhospital.com.
  • Hochman JS; NYU-HHC Clinical and Translational Science Institute, New York University School of Medicine, NYU Langone Health, New York, NY. Electronic address: Judith.Hochman@nyulangone.org.
  • Kapur NK; The CardioVascular Center, Tufts Medical Center Boston, MA. Electronic address: nkapur@tuftsmedicalcenter.org.
  • Laschinger J; U.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis (OCEA), 10903 New Hampshire Ave, Silver Spring, MD. Electronic address: john.laschinger@fda.hhs.gov.
  • Masters RG; University of Ottawa Heart Institute, Medical Adviser Health Canada, Ottawa, Ontario. Electronic address: roy.masters@canada.ca.
  • Michelson E; Thomas Jefferson University, Philadelphia, PA. Electronic address: eric.michelsonmd@gmail.com.
  • Morrow DA; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: DMORROW@BWH.HARVARD.EDU.
  • Morrow V; Duke Clinical Research Institute, Durham, NC. Electronic address: Valarie.morrow@duke.edu.
  • Ohman EM; Duke Program for Advanced Coronary Disease, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. Electronic address: erik.ohman@duke.edu.
  • Pina I; Wayne State University, Detroit, MI. Electronic address: Ileana.Pina@fda.hhs.gov.
  • Proudfoot AG; Department of Perioperative Medicine, St. Bartholomew's Hospital, London. Electronic address: Alastair.Proudfoot@bartshealth.nhs.uk.
  • Rogers J; Duke University Health System, Durham, NC. Electronic address: joseph.rogers@duke.edu.
  • Sapirstein J; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Washington, DC.
  • Senatore F; Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Washington, DC. Electronic address: Fortunato.Senatore@fda.hhs.gov.
  • Stockbridge N; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, 10903 New Hampshire Ave, Silver Spring, MD. Electronic address: norman.stockbridge@fda.hhs.gov.
  • Thiele H; Heart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology Leipzig, Germany, Leipzig Heart Institute, Leipzig, Germany. Electronic address: Holger.Thiele@medizin.uni-leipzig.de.
  • Truesdell AG; Virginia Heart, INOVA Heart and Vascular Institute, Alexandria, VA. Electronic address: atruesdell@tcg.md.
  • Waksman R; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC. Electronic address: Ron.waksman@medstar.net.
  • Rao S; Duke University Health System Section Chief, Cardiology, Durham VA Health System, Durham, NC. Electronic address: sunil.rao@duke.edu.
Am Heart J ; 219: 1-8, 2020 01.
Article em En | MEDLINE | ID: mdl-31707323
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Circulação Assistida / Choque Cardiogênico / Conferências de Consenso como Assunto / Ensaios Clínicos Controlados Aleatórios como Assunto / Medicina Baseada em Evidências / Comitês Consultivos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Circulação Assistida / Choque Cardiogênico / Conferências de Consenso como Assunto / Ensaios Clínicos Controlados Aleatórios como Assunto / Medicina Baseada em Evidências / Comitês Consultivos Idioma: En Ano de publicação: 2020 Tipo de documento: Article